Publications by authors named "Chase Ladd"

Claim this Profile
A
Assessing patient risk, benefit, and outcomes in drug development: a decade of vemurafenib clinical trials.
Taylor Gardner, Jacob Duncan, Griffin K Hughes, Ryan McIntire, Brooke Gardner, Chase Ladd

Melanoma Manag· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.
Varun Jhanji, Jacob Duncan, Taylor Gardner, Griffin K Hughes, Ryan McIntire, Chase Ladd

Mol Cancer Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of patient-reported outcomes among epidural steroid injection clinical trials.
Adam Khan, Will Roberts, Chase Ladd, Caleb Smith, Alexander Douglas

Reg Anesth Pain Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of selinexor's clinical trial portfolio: a cross-sectional study.
Annes Elfar, Andrew V Tran, Joseph Case, Cole Wayant, Griffin K Hughes, Chase Ladd

Ther Adv Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications.
Rafe Hunter Hall, Carson L Wright, Griffin K Hughes, Andriana M Peña, Chase Ladd

Clin Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.
Adam Khan, Hassan Khan, Griffin K Hughes, Chase Ladd, Ryan McIntire

Cancer Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Lenvatinib Clinical Trials: A Systematic Review.
Patrick Crotty, Karim Kari, Griffin K Hughes, Chase Ladd, Ryan McIntire

Target Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials.
Brody Dennis, Chance Bratten, Griffin K Hughes, Andriana M Peña, Ryan McIntire, Chase Ladd

BMJ Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the underreporting of patient-reported outcomes in carpal tunnel syndrome randomized controlled trials.
Chase Ladd, Samuel M Jacobsen, Kelsey Snider, Rigel Bacani, Cody Hillman

J Osteopath Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of reporting guidelines and Clinical Trial Registry requirements among anesthesiology journals.
Chase Ladd, Mary C Greenough, Arjun K Reddy, Elizabeth Garrett, Alyssa Peterson

J Evid Based Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Analysis of the Evidence Underpinning the American Urologic Association Clinical Practice Guidelines.
Andriana M Peña, Chase C Ladd, J Michael Anderson, Trevor Torgerson, Micah Hartwell

Urology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis